Transfusions for anemia in adult and pediatric patients with malignancies

Blood Reviews

Volumn 29, Issue 5, 2015, Pages 291-299

  Shah, Neil ^a   Andrews, Jennifer ^a   Goodnough, Lawrence Tim ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Anemia; Red blood cell transfusion; Restrictive vs liberal transfusion practices

Indexed keywords

HEMOGLOBIN;

ANEMIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD DONOR; CHRONIC LYMPHATIC LEUKEMIA; CYTOKINE RELEASE; DISEASE TRANSMISSION; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON THERAPY; LEUKEMIA; NONHODGKIN LYMPHOMA; PALLIATIVE THERAPY; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYMPTOMATOLOGY; VIRUS TRANSMISSION; WALDENSTROEM MACROGLOBULINEMIA; ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; COMPLICATION; FEMALE; MALE; NEOPLASM; PATHOPHYSIOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA; BLOOD TRANSFUSION; CHILD; FEMALE; HUMANS; MALE; NEOPLASMS; YOUNG ADULT;

EID: 84941259656     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2015.02.001     Document Type: Article

References (96)

1. Ludwig H., Van Belle S., Barrett-Lee P., Birgegard G., Bokemeyer C., Gascon P., et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004, 40:2293-2306.
2. Michon J. Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol 2002, 39:448-450.
3. Goodnough L.T., Levy J.H., Murphy M.F. Concepts of blood transfusion in adults. Lancet 2013, 381:1845-1854.
4. Goodnough L.T., Schrier S.L. Evaluation and management of anemia in the elderly. Am J Hematol 2014, 89:88-96.
5. Rodgers G.M., Becker P.S., Blinder M., et al. Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw 2012, 10:628-653.
6. Hockenberry M.J., Hinds P.S., Barrera P., Billups C., Rodriguez-Galindo C., Tan M., et al. Incidence of anemia in children with solid tumors or Hodgkin disease. J Pediatr Hematol Oncol. 2002, 24:35-37.
7. Weissinger F., Sandmaier B.M., Maloney D.G., Bensinger W.I., Gooley T., Storb R. Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood 2001, 98:3584-3588.
8. Roy C.N., Andrews N.C. Anemia of inflammation: the hepcidin link. Curr Opin Hematol 2005, 12:107-111.
9. Ruggiero A., Riccardi R. Interventions for anemia in pediatric cancer patients. Med Pediatr Oncol 2002, 39:451-454.
10. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
11. Gajewski J.L., Johnson V.V., Sandler S.G., Sayegh A., Klumpp T.R. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood 2008, 112:3036-3047.
12. Vlachaki E., Diamantidis M.D., Klonizakis P., Haralambidou-Vranitsa S., Ioannidou-Papagiannaki E., Klonizakis I. Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. Sci World J 2012, 2012:475313.
13. Engelen W., Verpooten G.A., Van der Planken M., Helbert M.F., Bosmans J.L., De Broe M.E. Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients. Clin Nephrol 2003, 60:119-124.
14. Rossert J., Casadevall N., Eckardt K.U. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol 2004, 15:398-406.
15. Gehrs B.C., Friedberg R.C. Autoimmune hemolytic anemia. Am J Hematol 2002, 69:258-271.
16. Paydas S. Fludarabine-induced hemolytic anemia: successful treatment by rituximab. Hematol J 2004, 5:81-83.
17. Franchini M., Di Minno M.N., Coppola A. Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost 2010, 36:388-403.
18. Langer F., Spath B., Haubold K., Holstein K., Marx G., Wierecky J., et al. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol. 2008, 87:451-457.
19. Zakarija A. Thrombotic microangiopathy syndromes. Cancer Treat Res 2009, 148:115-136.
20. Straus D.J., Testa M.A., Sarokhan B.J., Czuczman M.S., Tulpule A., Turner R.R., et al. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer. 2006, 107:1909-1917.
21. Choosing Wisely An initiative of the ABIM foundation (Accessed: 1/12/2015). http://www.choosingwisely.org/.
22. Carson J.L., Grossman B.J., Kleinman S., Tinmouth A.T., Marques M.B., Fung M.K., et al. Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB. Ann Intern Med. 2012, 157:49-58.
23. NCCN Clinical Practice Guidelines in Oncology NCCN guidelines: cancer-and chemotherapy-induced anemia Version2.2012, (Accessed 10/10/2014). http://www.nccn.org/professionals/physician_gls/PDF/anemia.pdf.
24. Goodnough L.T., Shander A. Current status of pharmacologic therapies in patient blood management. Anesth Analg 2013, 116:15-34.
25. Roseff S.D., Luban N.L., Manno C.S. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002, 42:1398-1413.
26. Perkins H.A., Busch M.P. Transfusion-associated infections: 50years of relentless challenges and remarkable progress. Transfusion 2010, 50:2080-2099.
27. US Food and Drug Administration Center for Biologics Evaluation and Research Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2011 (accessed Sept 2, 2014). http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM300764.pdf.
28. Vamvakas E.C. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 2005, 19:181-199.
29. Anderson K.C., Weinstein H.J. Transfusion-associated graft-versus-host disease. N Engl J Med 1990, 323:315-321.
30. Goodnough L.T., Murphy M.F. Do liberal blood transfusions cause more harm than good?. BMJ 2014, 349:g6897.
31. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4. CD002042.
32. Salpeter S.R., Buckley J.S., Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014, 127:124-131.e3.
33. Goodnough L.T. Blood management: Transfusion Medicine comes of age. Lancet 2013, 381:1791-1792.
34. Wang D., Sun J., Solomon S.B., Klein H.G., Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012, 52:1184-1195.
35. Steiner M.E., Triulzi D.J., Assmann S.F., Sloan S.R., Delaney M., Blajchman M.A., et al. Randomized trial results: red cell storage is not associated with a significant difference in multiple-organ dysfunction score or mortality in transfused cardiac surgery patients. Transfusion 2014, 54:15A.
36. Goodnough L.T., Shander A. Patient blood management. Anesthesiology 2012, 116:1367-1376.
37. Goodnough L.T., Nemeth E., Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010, 116:4754-4761.
38. Goodnough L.T., Maniatis A., Earnshaw P., Benoni G., Beris P., Bisbe E., et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth. 2011, 106:13-22.
39. Salisbury A.C., Reid K.J., Alexander K.P., Masoudi F.A., Lai S.M., Chan P.S., et al. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. Arch Intern Med. 2011, 171:1646-1653.
40. Lacroix J., Hebert P.C., Hutchison J.S., Hume H.A., Tucci M., Ducruet T., et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007, 356:1609-1619.
41. Kirpalani H., Whyte R.K., Andersen C., Asztalos E.V., Heddle N., Blajchman M.A., et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006, 149:301-307.
42. Bell E.F., Strauss R.G., Widness J.A., Mahoney L.T., Mock D.M., Seward V.J., et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005, 115:1685-1691.
43. Kirpalani H, Bell E, D'Angio C, Hintz S, Kennedy K, Ohls R, et al. Transfusion of prematures (TOP) trial: does a liberal red blood cell transfusion strategy improve neurologically-intact survival of extremely-low-birth-weight infants as compared to a restrictive strategy? (Accessed: 10/16/2014). http://www.nichd.nih.gov/about/Documents/TOP_Protocol.pdf.
44. Bercovitz R.S., Quinones R.R. A survey of transfusion practices in pediatric hematopoietic stem cell transplant patients. J Pediatr Hematol Oncol 2013, 35:e60-e63.
45. Dorsey K.A., Moritz E.D., Steele W.R., Eder A.F., Stramer S.L. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010. Transfusion 2013, 53:1250-1256.
46. Fasano R., Luban N.L. Blood component therapy. Pediatr Clin North Am 2008, 55:421-445.
47. Olgun H., Buyukavci M., Sepetcigil O., Yildirim Z.K., Karacan M., Ceviz N. Comparison of safety and effectiveness of two different transfusion rates in children with severe anemia. J Pediatr Hematol Oncol 2009, 31:843-846.
48. Alam A., Lin Y., Lima A., Hansen M., Callum J.L. The prevention of transfusion-associated circulatory overload. Transfus Med Rev 2013, 27:105-112.
49. Ullrich C.K., Mayer O.H. Assessment and management of fatigue and dyspnea in pediatric palliative care. Pediatr Clin North Am 2007, 54:735-756.
50. Yennurajalingam S., Bruera E. Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA 2007, 297:295-304.
51. Razzouk B.I., Hord J.D., Hockenberry M., Hinds P.S., Feusner J., Williams D., et al. Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. J Clin Oncol. 2006, 24:3583-3589.
52. Goodnough L.T., Despotis G.J., Hogue C.W., Ferguson T.B. On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 1995, 60:473-480.
53. Finch C.A., Lenfant C. Oxygen transport in man. N Engl J Med 1972, 286:407-415.
54. Adams R.C., Lundy J.S. Anesthesia in cases of poor surgical risk: some suggestions for decreasing the risk. Surg Gynecol Obstet 1941, 71:1011-1014.
55. Carson J.L., Noveck H., Berlin J.A., Gould S.A. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002, 42:812-818.
56. van Woerkens E.C., Trouwborst A., van Lanschot J.J. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?. Anesth Analg 1992, 75:818-821.
57. Carson J.L., Duff A., Poses R.M., Berlin J.A., Spence R.K., Trout R., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996, 348:1055-1060.
58. Hebert P.C., Yetisir E., Martin C., Blajchman M.A., Wells G., Marshall J., et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med. 2001, 29:227-234.
59. Parrillo J.E. Journal supplements, anemia management, and evidence-based critical care medicine. Crit Care Med 2001, 29(Supplement):S139-S140.
60. Expert Working Group Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997, 156(Suppl. 11):S1-S24.
61. Wu W.C., Rathore S.S., Wang Y., Radford M.J., Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001, 345:1230-1236.
62. Goodnough L.T., Bach R.G. Anemia, transfusion, and mortality. N Engl J Med 2001, 345:1272-1274.
63. Carson J.L., Hill S., Carless P., Hebert P., Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002, 16:187-199.
64. Hebert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
65. Mudumbai S.C., Cronkite R., Hu K.U., Wagner T., Hayashi K., Ozanne G.M., et al. Association of admission hematocrit with 6-month and 1-year mortality in intensive care unit patients. Transfusion. 2011, 51:2148-2159.
66. Hajjar L.A., Vincent J.L., Galas F.R., Nakamura R.E., Silva C.M., Santos M.H., et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010, 304:1559-1567.
67. Carson J.L., Terrin M.L., Noveck H., Sanders D.W., Chaitman B.R., Rhoads G.G., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011, 365:2453-2462.
68. Villanueva C., Colomo A., Bosch A., Concepcion M., Hernandez-Gea V., Aracil C., et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013, 368:11-21.
69. Carson J.L., Brooks M.M., Abbott J.D., Chaitman B., Kelsey S.F., Triulzi D.J., et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013, 165:964-971.
70. Holst L.B., Haase N., Wetterslev J., Wernerman J., Guttormsen A.B., Karlsson S., et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014, 371:1381-1391.
71. Consensus conference Perioperative red blood cell transfusion. JAMA 1988, 260:2700-2703.
72. Welch H.G., Meehan K.R., Goodnough L.T. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992, 116:393-402.
73. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996, 84:732-747.
74. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006, 105:198-208.
75. Innes G. Guidelines for red blood cells and plasma transfusion for adults and children: an emergency physician's overview of the 1997 Canadian blood transfusion guidelines. Part 1: red blood cell transfusion. Canadian Medical Association Expert Working Group. J Emerg Med 1998, 16:129-131.
76. Simon T.L., Alverson D.C., AuBuchon J., Cooper E.S., DeChristopher P.J., Glenn G.C., et al. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med. 1998, 122:130-138.
77. Murphy M.F., Wallington T.B., Kelsey P., Boulton F., Bruce M., Cohen H., et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol. 2001, 113:24-31.
78. British Committee for Standards in Haematology (BCSH) Guideline on the administration of blood components (Accessed: 1/20/2015). http://www.bcshguidelines.com/documents/BCSH_Blood_Admin_-_addendum_August_2012.pdf.
79. Australasian Society of Blood Transfusion Clinical practice guidelines: appropriate use of red blood cells Accessed: 1/20/2015. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp78.pdf.
80. Ferraris V.A., Ferraris S.P., Saha S.P., Hessel E.A., Haan C.K., Royston B.D., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007, 83:S27-86.
81. Ferraris V.A., Brown J.R., Despotis G.J., Hammon J.W., Reece T.B., Saha S.P., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011, 91:944-982.
82. Napolitano L.M., Kurek S., Luchette F.A., Corwin H.L., Barie P.S., Tisherman S.A., et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med. 2009, 37:3124-3157.
83. Napolitano L.M., Kurek S., Luchette F.A., Anderson G.L., Bard M.R., Bromberg W., et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma. 2009, 67:1439-1442.
84. Shander A., Fink A., Javidroozi M., Erhard J., Farmer S.L., Corwin H., et al. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev. 2011, 25:232-246.
85. KDIGO Clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012, 2:311-316.
86. National Blood Authority, Australia Patient blood management guidelines (Accessed 1/20/2015). http://www.nba.gov.au/guidelines/review.html.
87. Carson J.L., Hebert P.C. Should we universally adopt a restrictive approach to blood transfusion? It's all about the number. Am J Med 2014, 127:103-104.
88. Callum J.L., Waters J.H., Shaz B.H., Sloan S.R., Murphy M.F. The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion 2014, 54:2344-2352.
89. Adams E.S., Longhurst C.A., Pageler N., Widen E., Franzon D., Cornfield D.N. Computerized physician order entry with decision support decreases blood transfusions in children. Pediatrics 2011, 127:1112-1119.
90. Goodnough L.T., Shieh L., Hadhazy E., Cheng N., Khari P., Maggio P. Improved blood utilization using real-time clinical decision support. Transfusion 2014, 54:1358-1365.
91. Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion Epub 7/4/2014, 10.1111/trf.12723.
92. Goodnough L.T., Shah N. The next chapter in patient blood management: real-time clinical decision support. Am J Clin Pathol 2014, 142:741-747.
93. Birgegard G. Managing anemia in lymphoma and multiple myeloma. Ther Clin Risk Manag 2008, 4:527-539.
94. Gilreath J.A., Stenehjem D.D., Rodgers G.M. Diagnosis and treatment of cancer-related anemia. Am J Hematol 2014, 89:203-212.
95. Bohlius J., Weingart O., Trelle S., Engert A. Cancer-related anemia and recombinant human erythropoietin-an updated overview. Nat Clin Pract Oncol 2006, 3:152-164.
96. Shankar A.G. The role of recombinant erythropoietin in childhood cancer. Oncologist 2008, 13:157-166.